Cargando…

TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis

Background and Aims: The association between portal-systemic shunt and hepatocellular carcinoma (HCC) development in patients who have cirrhosis is still controversial. This systematic review with meta-analysis was performed to systematically clarify the potential role of portal-systemic shunt in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bin, Pang, Long, Chen, Hao-Bin, Wu, Dong-Bo, Wang, Yong-Hong, Chen, En-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783677/ https://www.ncbi.nlm.nih.gov/pubmed/31608215 http://dx.doi.org/10.14218/JCTH.2019.00007

Ejemplares similares

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

Evaluation of fibrosis in cirrhotic elderly patients with HCC
por: Pesce, A, et al.
Publicado: (2011)

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
por: Schütte, Kerstin, et al.
Publicado: (2014)

Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
por: Huang, Daniel Q., et al.
Publicado: (2020)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
por: Sydor, Svenja, et al.
Publicado: (2020)

Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy?
por: Jin, Chen, et al.
Publicado: (2017)

Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis
por: Zhang, Jian-Bin, et al.
Publicado: (2021)

Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial
por: Wang, Lei, et al.
Publicado: (2016)

Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
por: Wang, Liming, et al.
Publicado: (2018)

Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients
por: Lee, Yun Bin, et al.
Publicado: (2018)

Deal a death blow! HCC in cirrhotics – thrombotic complications: their frequency, characteristics, and risk factors
por: Mahmood, Khalid, et al.
Publicado: (2018)

Effects of Late Evening Snack on Cirrhotic Patients: A Systematic Review and Meta-Analysis
por: Guo, Ying-jie, et al.
Publicado: (2018)

The effects and safety of anticoagulation or antiplatelet therapy following TIPS in cirrhotic patients with portal hypertension: A meta-analysis
por: Xu, Xiaotong, et al.
Publicado: (2023)

Do cirrhotic patients with a high MELD score benefit from TIPS?
por: Choe, Won Hyeok
Publicado: (2014)

Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites
por: Yan, Huzheng, et al.
Publicado: (2020)

PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks
por: Zhou, Yongjie, et al.
Publicado: (2020)

Multidisciplinary care for patients with HCC: a systematic review and meta-analysis
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
por: SALVI, ALESSANDRO, et al.
Publicado: (2012)

Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
por: Fichtl, Anna, et al.
Publicado: (2023)

Use of proton pump inhibitors is associated with a higher risk of pneumonia in cirrhotic patients: a systematic review and meta-analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2020)

Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS
por: Chen, Hui, et al.
Publicado: (2013)

Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
por: Coppola, Nicola, et al.
Publicado: (2016)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
por: Morisco, Filomena, et al.
Publicado: (2021)

US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
por: Zhou, Hang, et al.
Publicado: (2021)

HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?
por: Costentin, Charlotte E., et al.
Publicado: (2021)

Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
por: Dong, Yinying, et al.
Publicado: (2019)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension
por: Qiu, Zhenkang, et al.
Publicado: (2022)

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
por: Liu, Lei, et al.
Publicado: (2014)

Perihepatic Biloma in a Non-cirrhotic Patient After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Mehmood, Faisal, et al.
Publicado: (2022)

No Differences in Rotational Thromboelastometry Measurements between Portal and Peripheral Circulation in Cirrhotic Patients Undergoing TIPS
por: Bedreli, Sotiria, et al.
Publicado: (2023)

The Association of HMGB1 Gene with the Prognosis of HCC
por: Xiao, Jianbiao, et al.
Publicado: (2014)

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
por: Fan, Wenzhe, et al.
Publicado: (2021)

TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience
por: Yan, Huzheng, et al.
Publicado: (2022)

Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach
por: Zhen, Cheng, et al.
Publicado: (2017)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients
por: Zheng, Bo-Hao, et al.
Publicado: (2018)

Tumor-Linked Macrophages Promote HCC Development by Mediating the CCAT1/Let-7b/HMGA2 Signaling Pathway
por: Deng, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qob2ge4v0gsoe5iks3cendekh1